Ardelyx Inc
Ardelyx Inc (ARDX) Implied Volatility Current
ARDX implied volatility is 271%. IV Rank is 99%, placing current premiums in the top of their 52-week range.
Read more
Tracking ARDX implied volatility helps you identify when options premiums on Ardelyx Inc are historically cheap or expensive, and where the best trades are hiding. Ardelyx Inc implied volatility reflects the market's expectation of future price movement: when ARDX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Ardelyx Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ARDX, tracking metrics like ARDX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ARDX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.
The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ARDX implied volatility sits today versus where it has been. Our scanner ranks Ardelyx Inc implied volatility against its historical range, surfaces extremes in ARDX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Ardelyx Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is near its yearly peak - premiums are expensive, favoring sellers.
As of September 18, 2026
Trade options with IV on your side
Track ARDX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→